Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment. [electronic resource]
Producer: 20120829Description: 125-36 p. digitalISSN:- 1879-1891
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Choroid Diseases -- drug therapy
- Coloring Agents
- Complement Factor H -- genetics
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Genotype
- Humans
- Indocyanine Green
- Intravitreal Injections
- Male
- Peripheral Vascular Diseases -- drug therapy
- Polymorphism, Single Nucleotide
- Polyps -- drug therapy
- Proteins -- genetics
- Ranibizumab
- Retrospective Studies
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.